Skip to main content
Premium Trial:

Request an Annual Quote

Dx Focus: Focus Diagnostics' Simplexa Flu A/B & RSV Test

Premium

Focus Diagnostics, a subsidiary of Quest Diagnostics, said this week that the US Food and Drug Administration has granted 510(k) clearance and CLIA moderate-complexity categorization to Focus' Simplexa Flu A/B & RSV direct test on the 3M Integrated Cycler.

The new test aids in the qualitative detection and differentiation of RNA from influenza A and B viruses and respiratory syncytial virus. Focus and 3M co-developed the assay through an exclusive global collaboration, and with the support of a $5.9 million contract from the Biomedical Advanced Research and Development Authority.

The companies have also marketed several other tests under the Simplexa brand name, including the first FDA-cleared commercial test for influenza A H1N1 (2009). Simplexa Flu A/B & RSV Direct is the first moderate-complexity molecular test in the Simplexa product line. Focus received 510(k) approval for a high-complexity version of the test in December 2010 (PCR Insider, 12/2/2010).

CLIA-designated moderate complexity laboratories include certain types of physician's offices, community hospitals, health clinics, and integrated delivery networks.

The test was CE Marked for distribution in Europe last year.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.